BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.

All News BrightGene Bio-Medical Technology Co., Ltd.

Equities

688166

CNE100003PR1

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
35.53 ^CNY	-1.93%		-0.59%	+1.51%

07/05	China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7%	MT
07/05	BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3%	MT

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7%	07/05	MT
BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3%	07/05	MT
BrightGene Bio-Medical Technology Co., Ltd. announced that it expects to receive CNY 499.999987 million in funding	06/05	CI
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	27/04	CI
Tranche Update on BrightGene Bio-Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/04	CI
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/02	CI
BrightGene Bio-Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	07/02	CI
BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.	06/02	CI
Oralead Pharma announced that it has received funding from HighLight Capital, Shenzhen Qianhai BangQin Investment Co., Ltd., BrightGene Bio-Medical Technology Co., Ltd., Shenyang Borui Pharmaceutical Co., Ltd.	29/01	CI
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Chinese Regulator Issues Warning Against BrightGene Bio-Medical Chairman Over Weight Loss Claims	19/23/19	MT
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs	17/23/17	MT
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
BrightGene Bio-Medical Technology's Unit Gets Hospital's Approval for Diabetes Drug Trial	27/23/27	MT
Chinese Drug Regulator Certifies Two Drugs of BrightGene's Unit	06/23/06	MT
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
BrightGene Bio-Medical to Hike Investment in API Production Project to 500 Million Yuan	08/23/08	MT
Xinchuang Biomedical Technology Subsidiary Gets Nod to Hold Anti-Diabetes Drug Trial	30/22/30	MT
BrightGene Bio-Medical Technology Co., Ltd. announced that it has received CNY 226.613082 million in funding from Horizon Asset Management Co. Ltd., Shanghai Leitu Asset Management Co., Ltd. and other investors	21/22/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News BrightGene Bio-Medical Technology Co., Ltd.

Equities

688166

CNE100003PR1

All News

Filters